Navigation Links
Hemophilia Pipeline Overview - Once-a-week prophylaxis may soon become a reality
Date:12/13/2012

NEW YORK, Dec. 13, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Hemophilia Pipeline Overview – Once-a-week prophylaxis may soon become a reality 

http://www.reportlinker.com/p01055538/Hemophilia-Pipeline-Overview-–-Once-a-week-prophylaxis-may-soon-become-a-reality.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology 

Among the products for hemophilia A and B that are likely to reach the market within the next 4 years are modified recombinant factor replacements that could reduce injection frequencies significantly, making once-a-week prophylaxis a reality.Assess key pipeline products with regards to current gold-standard therapies.Identify the prospects faced by next-generation products in this niche market.Review and profile current key pipeline hemophilia A and B factor replacement products.Assess current unmet needs and challenges faced by pipeline products.

The most important unmet need is a longer half-life for clotting factors so that daily intravenous injections are no longer necessary. Moving from daily to weekly or fortnightly injections would improve patients' quality of life enormously.

Since longer clotting factor half-life is the major unmet need in hemophilia treatment, Datamonitor believes that novel
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novo Nordisk introduces HemaGo, a mobile application to track hemophilia treatment, bleeding episodes and life events
2. Bayers Second Annual Virtual Walk for Hemophilia Raises Funds, Generates Excitement in the Hemophilia Community
3. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
4. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
5. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
6. Bausch + Lomb Product, Platform and Pipeline Innovations on Display at the Annual Meeting of the American Academy of Ophthalmology
7. Chronic Heart Failure (CHF) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
8. Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth
9. Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets
10. Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
11. Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015  Sequenom, Inc. (NASDAQ: ... healthier lives through the development of innovative products and ... Laboratories, will move its laboratory operations in ... Raleigh Durham , North Carolina.  Sequenom ... performed at the North Carolina ...
(Date:5/27/2015)... , May 27, 2015 OpportunityAnalyzer: ... 2018 Summary GlobalData estimates that the ... market was approximately $179m across the 6MM covered ... are investing their attention, time, and financial resources ... of research and development (R&D) strategies. One notable ...
(Date:5/27/2015)... , May 27, 2015 Protein purification involves ... on differences in their physical properties. The objective of ... amount of functional protein with fewest contaminants. The global ... at a CAGR of around 5% to 6% during ... increased research in the pharmaceutical and biotechnological fields, growing ...
Breaking Medicine Technology:Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 3OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 2OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 3OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 4Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 2Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 3
... Phase III Study Provides Further Evidence of,the ... the Treatment,of Rheumatoid Arthritis, BASEL, Switzerland, June ... second multinational phase III Actemra,(tocilizumab) study, successfully ... greater proportion of patients treated with Actemra,in ...
... Production Through Inhibition,of PDE-4 Enzyme, PALO ALTO, ... a privately held pharmaceutical company, announced,today the ... of,AN2728, a first-in-class topical therapy under investigation ... AN2728 to be,well-tolerated, with activity comparable to ...
Cached Medicine Technology:New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 2New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 3New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 4Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory,Compound, Shows Efficacy in Psoriasis 2
(Date:5/28/2015)... 28, 2015 Orem, UT—Dymicron, Inc., (dymicron.com) ... using their unique Triadyme-C cervical total disc replacement device. ... William D. Smith at the American Institute of Minimally ... are responding well to the implantation of the Dymicron ... Spine Center and Chief of Neurosurgery for the University ...
(Date:5/28/2015)... Omaha, NE (PRWEB) May 28, 2015 ... healthcare staffing, including nurse practitioner jobs, has announced that ... Association of Nurse Practitioners’ 2015 National Conference to be ... , AANP offers educational programming, networking opportunities, and ... Aureus Medical’s Advanced Practice division will be ...
(Date:5/28/2015)... 2015 Peggy J. Lynam, PT, DPT, NCS ... American Physical Therapy Association House of Delegates for the New ... Delegate Assembly. This will be her second term. ... coordinator and principle spokesperson for the Chapter delegation and presides ... or Delegate Assembly may direct the Chief Delegate to present ...
(Date:5/27/2015)... Gravity and volume loss in the skin have ... Holly CaSaroll, is excited to introduce a custom menu ... face, without surgical intervention, and without downtime. , “We ... approved procedure that can lift skin using focused ultrasound, ... new more lifting formula than its predecessor Radiesse, to ...
(Date:5/27/2015)... Thermage was the first to come out with ... 2007 coinciding with the release of NXT or CPT, the ... Aesthetics was the first practice in New York to debut ... results that had never been achieved before non-surgically. Even ... considered by many as the leading skin tightening device. ...
Breaking Medicine News(10 mins):Health News:Dymicron, Inc., Announces the First Human Implantation of their Triadyme-CTM Cervical Total Disc Replacement Device in Cyprus 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2Health News:Skin Expert Holly CaSaroll Announces New Cutting Edge Results with RadiessePlus Filler Available at Detroit Skin and Wellness Clinic 2Health News:Non-Surgical Fat Reduction and Skin Tightening Procedures, Thermage and Exilis, Increase 200% at Precision Aesthetics in New York, April 2015 2
... hospital ranked as one of Americas Best by U.S. News ... days than those admitted to a non-ranked hospital , according ... of Internal Medicine, one of the JAMA/Archives journals. ... mortality measures that are publicly reported by the Centers for ...
... eating uncooked fish dishes like koi-pla puts people in ... cause a type of liver cancer called cholangiocarcinoma ... weeks PLoS Medicine. ,Banchob Sripa (Khon Kaen ... food-borne trematode Opisthorchis viverrini (the SE Asian liver fluke) ...
... research, published in the July issue of the journal ... method for enhancing the potency and effectiveness of ... a variety of human cancers. , A ... human cancer cells to a promising treatment currently being ...
... According to a study published in the July 10, ... American Academy of Neurology , People with early Parkinsons ... of hallucinations, sleepiness, and swelling. ,By identifying ... for early intervention and possibly reduce disability, said study ...
... fashion designer Giorgio Armani's group said Wednesday it will open ... of both hot springs and high fashion. ... Ginza, one of Tokyo's ritziest districts, as part of its ... market. ,The 6,000 square-meter (65,000 square-foot) complex opening ...
... of British scientists claims they can soon release the worlds ... so, the NHS Trust of UK will stand to save billions ... most common neurological diseases in the western world, costs the NHS ... scientists, they have identified a series of proteins, which are most ...
Cached Medicine News:Health News:Americas Best Hospital Reduced Heart Attack Rates 2Health News:Americas Best Hospital Reduced Heart Attack Rates 3Health News:New Cancer Therapy in Clinical Trial 2Health News:Early Parkinsons Show Hallucination,sleepiness 2Health News:Simple Blood Test May Predict Alzheimers Disease 2
... Ultra thin collagen coated highly ... ultra thin wall construction offers ... The Hemacarotid UltraThin Patch provides ... conformability, and healing, without suture ...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
D-Stat Radial is a dry version of the D-Stat together with a compression band, and is designed for the control of surface bleeding from vascular access sites, including the sites on the radial artery...
... EVS is engineered to close arteriotomies ... ergonomic stapler with a simple trigger ... A deliver sheath gently locks ... control of the site before, during, ...
Medicine Products: